查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1573161

心血管手術設備市場：按產品類型、手術類型和最終用戶分類 - 全球預測 2025-2030 年

Cardiovascular Surgery Devices Market by Product Type (Cardiopulmonary Bypass Equipment, Heart Valve Devices, Perfusion Disposables), Procedure Type (Cardiovascular Surgery, Coronary Artery Bypass Grafting (CABG)), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心血管手術器械市場價值為15.7億美元，預計到2024年將達到16.5億美元，複合年成長率為5.43%，到2030年將達到22.7億美元。

心血管手術設備市場包括各種專為診斷、治療和管理心血管疾病而設計的儀器和設備。該市場包括冠狀動脈繞道手術手術（CABG）、心臟瓣膜修復和心臟瓣膜置換術等外科手術的基本設備，如心肺機、導管、支架和移植物。由於人口老化、久坐的生活方式和肥胖率的增加，心血管疾病的發生率不斷增加，因此需要這些設備。這些設備用於醫院、心臟專科護理中心、門診病人設施等，在傳統手術和微創手術中發揮重要作用。

主要市場統計
基準年[2023] 15.7億美元
預測年份 [2024] 16.5億美元
預測年份 [2030] 22.7億美元
複合年成長率（%） 5.43%

市場成長受到多種因素的影響，例如技術進步、對微創手術的日益偏好以及主要企業的大量研發投資。最近的趨勢，例如將人工智慧和物聯網整合到手術設備中，透過提供即時資料分析和預測結果來提高手術成功率，從而釋放潛在的機會。鼓勵公司專注於產品創新、基於價值的護理模式和策略夥伴關係關係，以利用這些機會。相反，高昂的設備成本、嚴格的監管核准以及缺乏熟練的外科醫生等限制因素給市場擴張帶來了挑戰。特別是在新興市場，監管合規障礙可能會阻礙產品的快速發布和採用。

生物可吸收血管支架、機器人輔助手術以及結合傳統技術和導管技術的混合導管實驗室手術環境等領域存在大量創新和研究機會。開發提高手術精度和縮短恢復時間的解決方案可以提供競爭優勢。此外，由於快速的技術變革和醫療保健報銷政策，市場的本質是高度動態的。透過專注於這些創新路徑並適應監管環境，公司可以在這個不斷發展的生態系統中獲得強大的地位，並永續地滿足對有效心血管手術解決方案不斷成長的需求，從而促進成長。

市場動態：快速發展的心血管手術器材市場的關鍵市場洞察

供需的動態交互作用正在改變心血管手術器械市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 由於生活方式和飲食的改變導致心血管疾病的盛行率增加，導致手術干預的增加
    • 心血管手術設備的快速技術進步和創新可改善患者的治療效果
    • 由於人口老化更容易罹患心臟病，心血管手術的需求增加
    • 擴大新興市場的醫療保健基礎設施和先進醫療設施
  • 市場限制因素
    • 心血管外科的先進手術和材料高成本
  • 市場機會
    • 將人工智慧和機器學習整合到手術設備中
    • 心血管手術器械：由於技術進步和人口老化，對微創手術的需求不斷成長
  • 市場挑戰
    • 替代療法和非侵入性心血管手術的競爭加劇。

波特五力：駕馭心血管手術器械市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心血管手術器械市場的外部影響

外部宏觀環境因素在塑造心血管手術器械市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解心血管手術器材市場的競爭格局

心血管手術設備市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣心血管手術器械市場供應商的績效評估

FPNV 定位矩陣是評估心血管手術設備市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了心血管手術器械市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對心血管手術器械市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 生活方式和飲食的改變正在增加心血管疾病的發生率並增加對手術干預的需求。
      • 心血管手術設備的快速技術進步和創新可改善患者的治療效果
      • 由於人口老化，更容易患心臟病，對心血管手術的需求不斷增加。
      • 擴大新興市場的醫療保健基礎設施和先進醫療設施
    • 抑制因素
      • 心血管外科的先進手術和材料高成本
    • 機會
      • 將人工智慧和機器學習整合到手術設備中
      • 技術進步和人口老化正在增加對微創心血管手術設備的需求
    • 任務
      • 來自替代療法和非侵入性心血管手術的競爭正在加劇。
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章心血管手術器械市場：依產品類型

  • 心肺機
    • 插管
    • 供氧裝置
    • 水庫
  • 心臟瓣膜裝置
    • 人工心臟瓣膜
    • 組織心臟瓣膜
    • 經導管心臟瓣膜
  • 拋棄式
    • 血液心臟麻痹

第7章依手術類型分類的心血管手術器械市場

  • 心血管外科
  • 冠狀動脈繞道手術手術（CABG）

第8章心血管手術設備市場：依最終用戶分類

  • 心臟中心
  • 醫院

第9章美洲心血管手術器械市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區心血管手術器械市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲心血管手術器材市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議
Product Code: MRR-535C6291876B

The Cardiovascular Surgery Devices Market was valued at USD 1.57 billion in 2023, expected to reach USD 1.65 billion in 2024, and is projected to grow at a CAGR of 5.43%, to USD 2.27 billion by 2030.

The cardiovascular surgery devices market encompasses a broad array of instruments and equipment designed for the diagnosis, treatment, and management of cardiovascular disorders. This market includes devices such as heart-lung machines, catheters, stents, and grafts, essential for surgical procedures like coronary artery bypass grafting (CABG), heart valve repair, and replacement. The necessity of these devices stems from the rising incidence of cardiovascular diseases fueled by aging populations, sedentary lifestyles, and increasing obesity rates. These devices find application in hospitals, specialized cardiac care centers, and outpatient facilities, serving a critical role in both conventional and minimally invasive surgical procedures.

KEY MARKET STATISTICS
Base Year [2023] USD 1.57 billion
Estimated Year [2024] USD 1.65 billion
Forecast Year [2030] USD 2.27 billion
CAGR (%) 5.43%

Market growth is influenced by several factors, including technological advancements, growing preference for minimally invasive surgery, and extensive R&D investment by key players. Recent trends such as the integration of AI and IoT in surgical devices have unlocked potential opportunities by offering real-time data analytics and predictive outcomes, improving surgery success rates. Companies are encouraged to focus on product innovation, value-based care models, and strategic partnerships to leverage these opportunities. Conversely, limitations such as high device costs, stringent regulatory approvals, and the shortage of skilled surgeons pose challenges to market expansion. Regulatory compliance hurdles, particularly in emerging markets, can hinder swift product launches and adoption.

Opportunities for innovation and research are abundant in areas like bioresorbable vascular scaffolds, robot-assisted surgery, and hybrid cath lab operating environments where traditional and catheter-based procedures are combined. Developing solutions that enhance surgical precision and reduce recovery times can offer a competitive advantage. Additionally, the market nature is highly dynamic due to rapid technological shifts and healthcare reimbursement policies. By focusing on these innovation avenues and adapting to regulatory landscapes, businesses can position themselves strongly in this evolving ecosystem, driving sustained growth while meeting the increasing demand for efficient cardiovascular surgical solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiovascular Surgery Devices Market

The Cardiovascular Surgery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of cardiovascular diseases due to lifestyle and dietary changes leading to higher surgical interventions
    • Rapid technological advancements and innovation in cardiovascular surgery devices improving patient outcomes
    • Increasing aging population prone to heart conditions boosting demand for cardiovascular surgery procedures
    • Expansion of healthcare infrastructure and access to advanced medical facilities in emerging markets
  • Market Restraints
    • High Cost for advance procedure and material in cardiovascular surgery
  • Market Opportunities
    • Integration of artificial intelligence and machine learning in surgical device
    • Growing demand for minimally invasive cardiovascular surgery devices driven by technological advancements and aging population
  • Market Challenges
    • Increased competition from alternative treatments and non-invasive cardiovascular procedures.

Porter's Five Forces: A Strategic Tool for Navigating the Cardiovascular Surgery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiovascular Surgery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiovascular Surgery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiovascular Surgery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiovascular Surgery Devices Market

A detailed market share analysis in the Cardiovascular Surgery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiovascular Surgery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiovascular Surgery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiovascular Surgery Devices Market

A strategic analysis of the Cardiovascular Surgery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Canon Medical Systems Corporation, Edwards Lifesciences Corporation, Fresenius Medical Care AG & Co. KGaA, GE HealthCare Technologies Inc., Getinge AB, Johnson & Johnson, LivaNova PLC, Maquet Cardiovascular LLC, Medtronic plc, MicroPort Scientific Corporation, Philips Healthcare, Siemens Healthineers AG, St. Jude Medical, Inc., Stryker Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cardiopulmonary Bypass Equipment, Heart Valve Devices, and Perfusion Disposables. The Cardiopulmonary Bypass Equipment is further studied across Cannulae, Oxygenators, and Reservoirs. The Heart Valve Devices is further studied across Mechanical Heart Valves, Tissue Heart Valves, and Transcatheter Heart Valves. The Perfusion Disposables is further studied across Blood Cardioplegia.
  • Based on Procedure Type, market is studied across Cardiovascular Surgery and Coronary Artery Bypass Grafting (CABG).
  • Based on End User, market is studied across Cardiac Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of cardiovascular diseases due to lifestyle and dietary changes leading to higher surgical interventions
      • 5.1.1.2. Rapid technological advancements and innovation in cardiovascular surgery devices improving patient outcomes
      • 5.1.1.3. Increasing aging population prone to heart conditions boosting demand for cardiovascular surgery procedures
      • 5.1.1.4. Expansion of healthcare infrastructure and access to advanced medical facilities in emerging markets
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost for advance procedure and material in cardiovascular surgery
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of artificial intelligence and machine learning in surgical device
      • 5.1.3.2. Growing demand for minimally invasive cardiovascular surgery devices driven by technological advancements and aging population
    • 5.1.4. Challenges
      • 5.1.4.1. Increased competition from alternative treatments and non-invasive cardiovascular procedures.
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiovascular Surgery Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cardiopulmonary Bypass Equipment
    • 6.2.1. Cannulae
    • 6.2.2. Oxygenators
    • 6.2.3. Reservoirs
  • 6.3. Heart Valve Devices
    • 6.3.1. Mechanical Heart Valves
    • 6.3.2. Tissue Heart Valves
    • 6.3.3. Transcatheter Heart Valves
  • 6.4. Perfusion Disposables
    • 6.4.1. Blood Cardioplegia

7. Cardiovascular Surgery Devices Market, by Procedure Type

  • 7.1. Introduction
  • 7.2. Cardiovascular Surgery
  • 7.3. Coronary Artery Bypass Grafting (CABG)

8. Cardiovascular Surgery Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Cardiac Centers
  • 8.3. Hospitals

9. Americas Cardiovascular Surgery Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cardiovascular Surgery Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cardiovascular Surgery Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Biotronik SE & Co. KG
  • 3. Boston Scientific Corporation
  • 4. Canon Medical Systems Corporation
  • 5. Edwards Lifesciences Corporation
  • 6. Fresenius Medical Care AG & Co. KGaA
  • 7. GE HealthCare Technologies Inc.
  • 8. Getinge AB
  • 9. Johnson & Johnson
  • 10. LivaNova PLC
  • 11. Maquet Cardiovascular LLC
  • 12. Medtronic plc
  • 13. MicroPort Scientific Corporation
  • 14. Philips Healthcare
  • 15. Siemens Healthineers AG
  • 16. St. Jude Medical, Inc.
  • 17. Stryker Corporation
  • 18. Terumo Corporation
  • 19. W. L. Gore & Associates, Inc.
  • 20. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. CARDIOVASCULAR SURGERY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CARDIOVASCULAR SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CARDIOVASCULAR SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIOVASCULAR SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIOVASCULAR SURGERY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY RESERVOIRS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TISSUE HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY BLOOD CARDIOPLEGIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING (CABG), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 151. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 241. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 247. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. CARDIOVASCULAR SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 278. CARDIOVASCULAR SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023